Ladenburg Thalmann Financial Services’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PARN Stock Details PARN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,800	Closed	-$4K	–	5189
2016 Q4	$4K	Sell	6,800 -17,500	-72%	-$20.8K	﹤0.01%	4387
2016 Q3	$35K	Sell	24,300 -12,500	-34%	-$19.3K	﹤0.01%	3055
2016 Q2	$60K	Buy	36,800 +35,000	+1,944%	+$64.3K	﹤0.01%	2551
2016 Q1	$4K	Hold	1,800	–	–	﹤0.01%	4237
2015 Q4	$7K	Buy	+1,800	New	+$6.84K	﹤0.01%	3938
2015 Q3	–	Sell	-300	Closed	-$1K	–	4986
2015 Q2	$1K	Hold	300	–	–	﹤0.01%	4628
2015 Q1	$1K	Buy	+300	New	+$1.39K	﹤0.01%	4551

Other funds holding PARN

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Ladenburg Thalmann Financial Services's PARN Position: Q1 2017 in Review

Ladenburg Thalmann Financial Services sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2017, closing a stake of 6,800 shares — an estimated $4K sold.

Ladenburg Thalmann Financial Services first reported a position in PARN in Q1 2015 and held it in 7 quarters. The position peaked at $60K in Q2 2016. 2 funds tracked by Wall St. Rank hold PARN as of Q1 2017.

Ladenburg Thalmann Financial Services reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2017 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 6,800 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2017, an estimated $4K.
Ladenburg Thalmann Financial Services first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q1 2015 and held it in 7 quarters.
Ladenburg Thalmann Financial Services's Parnell Pharmaceuticals Holdings Ltd position peaked at $60K in Q2 2016.
2 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2017, filed 15 May 2017.